Business Description
Silco Pharmaceuticals Ltd
ISIN : BD0495SILCO6
Share Class Description:
DHA:SILCOPHL: Ordinary SharesDescription
Silco Pharmaceuticals Ltd is engaged in manufacturing and marketing of pharmaceuticals finished products in the categories of Antibiotics, Analgesics, Anti diabetics, Narcotics, Antipyratics, Anti-inflammatory Drugs, Antiulcerants, Multi medicines which are sold mainly in local market.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Piotroski F-Score | N/A/9 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.18 | |||||
| 9-Day RSI | 46.6 | |||||
| 14-Day RSI | 49.52 | |||||
| 6-1 Month Momentum % | -26.07 | |||||
| 12-1 Month Momentum % | -27.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.6 | |||||
| Forward Dividend Yield % | 1.6 | |||||
| 5-Year Yield-on-Cost % | 1.6 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | N/A |
N/A
|
N/A
|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Silco Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil BDT) | |||
| EPS (TTM) (BDT) | 0 | ||
| Beta | 0 | ||
| Volatility % | 30.33 | ||
| 14-Day RSI | 49.52 | ||
| 14-Day ATR (BDT) | 0.688058 | ||
| 20-Day SMA (BDT) | 18.765 | ||
| 12-1 Month Momentum % | -27.92 | ||
| 52-Week Range (BDT) | 16.2 - 25.9 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Silco Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Silco Pharmaceuticals Ltd Stock Events
| Event | Date | Price(BDT) | ||
|---|---|---|---|---|
| No Event Data | ||||
Silco Pharmaceuticals Ltd Frequently Asked Questions
What is Silco Pharmaceuticals Ltd(DHA:SILCOPHL)'s stock price today?
The current price of DHA:SILCOPHL is BDT18.80. The 52 week high of DHA:SILCOPHL is BDT25.90 and 52 week low is BDT16.20.
When is next earnings date of Silco Pharmaceuticals Ltd(DHA:SILCOPHL)?
The next earnings date of Silco Pharmaceuticals Ltd(DHA:SILCOPHL) is .
Does Silco Pharmaceuticals Ltd(DHA:SILCOPHL) pay dividends? If so, how much?
The Dividend Yield %  of Silco Pharmaceuticals Ltd(DHA:SILCOPHL) is 1.6% (As of Today), Highest Dividend Payout Ratio of Silco Pharmaceuticals Ltd(DHA:SILCOPHL) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Silco Pharmaceuticals Ltd(DHA:SILCOPHL) is 1.6%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers